Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination medication containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*).
## Primary Indications
* Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
* **Standard Regimen:** One 40 mg pantoprazole, 500 mg amoxicillin, and 250 mg clarithromycin capsule/tablet taken orally twice daily for 7 to 14 days.
## Pediatric Dosing
* Specific pediatric dosing for Sompraz HP is not well-established. Dosing of individual components (pantoprazole, amoxicillin, clarithromycin) should be based on age, weight, and indication according to pediatric guidelines.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment for pantoprazole is typically needed unless severe. Amoxicillin dose may need adjustment in severe renal impairment (CrCl < 30 mL/min). Clarithromycin dose should be reduced in significant renal impairment (CrCl < 30 mL/min).
* **Hepatic Impairment:** Pantoprazole dose reduction may be considered in severe hepatic impairment. Clarithromycin dose reduction is recommended in hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or other macrolides or penicillins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Use in patients with known severe renal impairment or creatinine clearance below 30 mL/min if used as a fixed-dose combination with amoxicillin.
* Concurrent use of cisapride, astemizole, terfenadine, pimozide, ergotamine, or dihydroergotamine with clarithromycin.
## Adverse Effects
Common adverse effects include diarrhea, nausea, vomiting, abdominal pain, headache, dysgeusia (altered taste), rash, and potential for *Clostridioides difficile*-associated diarrhea. Serious adverse effects include anaphylaxis, severe skin reactions, QT prolongation (clarithromycin), and *C. difficile* infection.
## Key Drug Interactions
* **Pantoprazole:** May decrease absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, atazanavir). Can interact with warfarin.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. May interact with methotrexate.
* **Clarithromycin:** Potent CYP3A4 inhibitor. Significant interactions with numerous drugs including statins, anticoagulants (e.g., warfarin), anticonvulsants (e.g., carbamazepine, phenytoin), antiarrhythmics (e.g., quinidine), colchicine, and immunosuppressants.
## Monitoring
* Monitor for signs of allergic reaction.
* Assess for efficacy of *H. pylori* eradication (usually 4-6 weeks post-treatment with urea breath test, stool antigen test, or biopsy).
* Monitor for *C. difficile*-associated diarrhea.
* Monitor liver function tests if prolonged therapy or history of liver disease.
## Clinical Pearls
* Administer the full course of therapy, even if symptoms improve, to ensure eradication.
* Take pantoprazole at least 30 minutes before meals. Amoxicillin and clarithromycin should be taken with food to minimize GI upset.
* Consider probiotics to help prevent antibiotic-associated diarrhea, although evidence is mixed.
* Resistance rates for *H. pylori* to clarithromycin can vary geographically; ensure this regimen is appropriate for your local resistance patterns.
***
*Please verify the most current prescribing information and local protocols for definitive guidance.*
